The US-China deal under negotiation is likely to bear similarities to the phase one trade agreement from Donald Trump’s first term, according to a former senior official in that administration ...

The Phase 1 study results of IBI343 in advanced gastric and gastroesophageal junction adenocarcinoma, now published in the top international journal, Nature Medicine, further verify the clinical value ...

The Invesco QQQ Trust has produced returns in excess of 400% during the past 10 years. Investing a regular amount per month in the fund can help you build a portfolio worth more than $1 million ...

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 liver disease study.

MindRank has shared the skinny on its oral GLP-1 receptor agonist, publishing data from a Chinese phase 2b obesity trial that suggests efficacy is in the same ballpark as Eli Lilly’s orforglipron.

Terns Pharmaceuticals announced positive Phase 1 data for TERN-601 and completed enrollment in the Phase 2 FALCON trial.

As with the growth ETF, if you invest $300 per month into this fund, you can also be on the path to a $1 million portfolio.

ChatGPT's image generator tool now takes requests at 1-800-CHATGPT. The feature, announced by OpenAI on Monday in a post on X, allows anyone with a WhatsApp account to text that phone number and ...

Turning $10,000 into $1 million demands a 100x return and 63% annual growth — tough but possible with the right investment.

It doubles as an observability tool that can monitor metrics such as a switch’s temperature and electricity usage. Alongside its networking equipment, Meter sells cybersecurity appliances.

Albany is the No. 2 seed for the NYSPHSAA track and field championships in the 4x100 relay after running a time of 41.93 earlier this season.